# FDA Inspection 1055316 - Alexander E. Drilon, M.D. - May 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/7eeb5080-1486-4bb4-b05d-bdda892a71db
Source feed: FDA_Inspections

> FDA Inspection 1055316 for Alexander E. Drilon, M.D. on May 17, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055316
- Company Name: Alexander E. Drilon, M.D.
- Inspection Date: 2018-05-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1306612 - 2026-03-03](https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/1636aa08-1220-4cc8-9bd5-040cfad42dab)
- [FDA Inspection 1209656 - 2023-06-16](https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/bcf8e434-62c0-45da-be1d-680257bd6c47)
- [FDA Inspection 1089078 - 2019-04-26](https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/af626bb4-9417-43d6-98f9-bf2da572b483)

Company: https://www.keypedia.com/companies/alexander-e-drilon-md/09292093-df70-41ce-a80b-6e7959abc03b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c